Saudi: Avalon Pharma unveils $6.66mln cash dividends for H2-24

The Saudi group will disburse SAR 1.25 per share, equivalent to 12.50% of the share’s nominal value, for 20mln eligible shares

Staff Writer, Mubasher

April 14, 2025

PHOTO

Riyadh – The board members of Middle East Pharmaceutical Industries Company (Avalon Pharma) approved dividends worth SAR 25 million for the second half (H2) of 2024, according to a bourse filing.

The Saudi group will disburse SAR 1.25 per share, equivalent to 12.50% of the share’s nominal value, for 20 million eligible shares.

Meanwhile, the eligibility and payment dates for the announced dividends will be 1 and 15 May 2025, respectively.

Avalon Pharma distributed SAR 15 million in cash dividends for H1-24 last September.

Source: Mubasher

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

ZAWYA NEWSLETTERS

RELATED ARTICLES

ZAWYA NEWSLETTERS

LATEST VIDEO